ZyCoV-D

Zydus Lifesciences said on Tuesday said a two-dose regimen of ZyCoV-D will help in administering the vaccine against coronavirus infections to a larger population in a shorter time. The…

Pharmaceutical company Zydus group on Wednesday announced that it had started the supply of its COVID-19 vaccine, ZyCoV-D, to the Central government against their order. The group is also…

“The vaccine will be priced at Rs 265 per dose and the applicator being offered at Rs 93 per dose, excluding GST,” Zydus Cadila said. Drug firm Zydus Cadila on Wednesday said it has…

MUMBAI: Sitting on a stockpile of almost 45 lakh unsold Covid-19 vaccine doses, private hospitals in Maharashtra are heaving a sigh of relief with the announcement of rollout of booster shot…

Nasal vaccine is administered through the nose and not syringe making it easy for application to children. It can generate an immune response at the site of infection within respiratory…

A total of 90 children were subjected to Covaxin trials in Karnataka. ‘Zydus Cadila, a leading pharmaceutical company in India was recently authorized by DCGI for its needle-free ZyCoV-D…

The Central Drugs Standard Control Organization's Subject Expert Committee has granted Zydus Cadila's three-dose vaccine emergency use authorization in India. The vaccine can be…

The Science and Technology Ministry statement said: "Zydus Cadila has received approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D…

If regulators consent, ZyCoV-D could become the second home-grown shot, after Bharat Biotech's Covaxin; and fourth to get a DCGI nod for use against the viral infection in India after…